Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.

Jiang C, Foley J, Clayton N, Kissling G, Jokinen M, Herbert R, Diaz M.

J Immunol. 2007 Jun 1;178(11):7422-31.

2.

Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.

Jiang C, Zhao ML, Scearce RM, Diaz M.

Arthritis Rheum. 2011 Apr;63(4):1086-96. doi: 10.1002/art.30230.

3.

The role of activation-induced deaminase in lupus nephritis.

Diaz M.

Autoimmunity. 2013 Mar;46(2):115-20. doi: 10.3109/08916934.2012.750303. Epub 2013 Jan 10. Review.

PMID:
23215788
4.

Deficiency in activation-induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background.

Chen L, Guo L, Tian J, Zheng B, Han S.

Clin Exp Immunol. 2010 Feb;159(2):169-75. doi: 10.1111/j.1365-2249.2009.04058.x. Epub 2009 Nov 18.

5.

Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis.

Jiang C, Zhao ML, Diaz M.

Immunology. 2009 Jan;126(1):102-13. doi: 10.1111/j.1365-2567.2008.02882.x. Epub 2008 Jun 20.

6.

AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.

White CA, Seth Hawkins J, Pone EJ, Yu ES, Al-Qahtani A, Mai T, Zan H, Casali P.

Autoimmunity. 2011 Dec;44(8):585-98. doi: 10.3109/08916934.2011.577128. Epub 2011 May 18. Erratum in: Autoimmunity. 2011 Dec;44(8):664.

7.

Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.

Liang B, Kashgarian MJ, Sharpe AH, Mamula MJ.

J Immunol. 2000 Sep 15;165(6):3436-43.

8.

Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.

Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.

J Immunol. 2012 Apr 15;188(8):3628-38. doi: 10.4049/jimmunol.1102859. Epub 2012 Mar 9.

9.
10.

Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.

Satoh M, Weintraub JP, Yoshida H, Shaheen VM, Richards HB, Shaw M, Reeves WH.

J Immunol. 2000 Jul 15;165(2):1036-43.

11.

Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice.

Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, Kelley VR.

J Immunol. 2000 Jun 1;164(11):6046-56.

13.
14.

Activation-induced deaminase contributes to the antibody-independent role of B cells in the development of autoimmunity.

Jiang C, Zhao ML, Waters KM, Diaz M.

Autoimmunity. 2012 Sep;45(6):440-8. doi: 10.3109/08916934.2012.682668. Epub 2012 Jun 25.

15.

Lupus nephritis in the absence of renal major histocompatibility complex class I and class II molecules.

Mukherjee R, Zhang Z, Zhong R, Yin ZQ, Roopenian DC, Jevnikar AM.

J Am Soc Nephrol. 1996 Nov;7(11):2445-52.

16.

Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.

Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW.

J Immunol. 1999 Sep 15;163(6):3153-9.

17.

Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.

Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS.

Kidney Int. 2004 Jan;65(1):129-38.

PMID:
14675043
18.
19.

Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice.

Bloom RD, O'Connor T, Cizman B, Kalluri R, Naji A, Madaio MP.

Int Immunol. 2002 Aug;14(8):867-71.

20.

Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice.

Sekine H, Watanabe H, Gilkeson GS.

J Immunol. 2004 Mar 15;172(6):3913-21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk